Matches in Wikidata for { <http://www.wikidata.org/entity/Q73668731> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q73668731 description "article scientifique publié en 2000" @default.
- Q73668731 description "artikull shkencor i botuar më 01 shkurt 2000" @default.
- Q73668731 description "artículu científicu espublizáu en febreru de 2000" @default.
- Q73668731 description "im Februar 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73668731 description "scientific article published on 01 February 2000" @default.
- Q73668731 description "wetenschappelijk artikel" @default.
- Q73668731 description "wüsseschaftlicher Artikel, wo im Hornig 2000 veröffentlicht worden isch" @default.
- Q73668731 description "наукова стаття, опублікована в лютому 2000" @default.
- Q73668731 name "Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer" @default.
- Q73668731 name "Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer" @default.
- Q73668731 name "Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer" @default.
- Q73668731 type Item @default.
- Q73668731 label "Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer" @default.
- Q73668731 label "Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer" @default.
- Q73668731 label "Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer" @default.
- Q73668731 prefLabel "Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer" @default.
- Q73668731 prefLabel "Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer" @default.
- Q73668731 prefLabel "Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer" @default.
- Q73668731 P1433 Q73668731-8B001679-8BB9-414A-96BC-347AE7EDDBC6 @default.
- Q73668731 P1476 Q73668731-CC393071-550C-4AE3-8242-C64FDE8474AA @default.
- Q73668731 P2093 Q73668731-2BDB8B50-D4AB-461E-A6B4-D41782E39DB0 @default.
- Q73668731 P2093 Q73668731-4B4B8FBD-7AED-44AA-9C20-17CE8C3170DC @default.
- Q73668731 P2093 Q73668731-67DFC12B-9706-4080-9A9D-AB9DCE523BA5 @default.
- Q73668731 P2093 Q73668731-AAD07C13-7DA9-44D4-A63C-884970BC2E90 @default.
- Q73668731 P2093 Q73668731-CA0E690B-FA3F-4C9A-AAB3-79DE1D6E46C1 @default.
- Q73668731 P2093 Q73668731-E83A78E3-C223-4C4B-958F-F5D68206DAA8 @default.
- Q73668731 P2860 Q73668731-003DA086-58CE-4871-8D9F-3E0838F0D600 @default.
- Q73668731 P2860 Q73668731-034DDF6D-6DCC-4BDB-86BD-C2D39F267658 @default.
- Q73668731 P2860 Q73668731-046DB41D-CA3C-4877-8206-849B19E5A096 @default.
- Q73668731 P2860 Q73668731-4727F889-AC14-4929-935C-78858AD0F219 @default.
- Q73668731 P2860 Q73668731-492936E4-6C8D-41CA-A870-002C090E3730 @default.
- Q73668731 P2860 Q73668731-56DE34D5-0141-46AB-9C40-96BBB6D3299F @default.
- Q73668731 P2860 Q73668731-6C2EC8AC-691A-4AFC-A1FE-A94C250F144E @default.
- Q73668731 P2860 Q73668731-747E3CF1-FFC2-4813-8514-EE44374F7AFA @default.
- Q73668731 P2860 Q73668731-8694934A-098A-4152-8C7D-9CF4B90BFE2E @default.
- Q73668731 P2860 Q73668731-E42700E1-453C-409A-BD6B-5235FBC7EE7C @default.
- Q73668731 P304 Q73668731-EAC75C78-6E1D-4D6E-8B9F-09470368C13B @default.
- Q73668731 P31 Q73668731-4D374A27-8554-402F-96E5-38427D0E14DF @default.
- Q73668731 P356 Q73668731-542D5FE0-04C6-4C33-8EC0-E8BBD84A6D37 @default.
- Q73668731 P433 Q73668731-365C618C-69F4-4641-A07E-35FAA0A6DF3C @default.
- Q73668731 P478 Q73668731-EBE96CA2-9685-4273-BE60-5F05AB381D34 @default.
- Q73668731 P577 Q73668731-3D1B30A8-F3F6-4D0D-AA56-C99B10FB58BA @default.
- Q73668731 P698 Q73668731-A6864912-7633-46FF-9A68-A1A008D0AD0D @default.
- Q73668731 P921 Q73668731-1BADA3D5-A0FE-417D-9941-709176D3F20B @default.
- Q73668731 P921 Q73668731-22FB8E8A-DB3D-4CFF-B506-5C23D3DB4B84 @default.
- Q73668731 P921 Q73668731-8829F36C-9940-451F-8573-138202CCDFFD @default.
- Q73668731 P921 Q73668731-9B87733A-4030-4E6F-A32E-76B51BCE3299 @default.
- Q73668731 P921 Q73668731-EEE9A035-7D38-4E4B-AC98-07C59E3DA88B @default.
- Q73668731 P356 A:1008358411251 @default.
- Q73668731 P698 10761749 @default.
- Q73668731 P1433 Q326122 @default.
- Q73668731 P1476 "Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer" @default.
- Q73668731 P2093 "A Bellanger" @default.
- Q73668731 P2093 "C Levy-Piedbois" @default.
- Q73668731 P2093 "C Schmitt" @default.
- Q73668731 P2093 "H Juhel" @default.
- Q73668731 P2093 "I Durand-Zaleski" @default.
- Q73668731 P2093 "P Piedbois" @default.
- Q73668731 P2860 Q34754672 @default.
- Q73668731 P2860 Q40840320 @default.
- Q73668731 P2860 Q41145868 @default.
- Q73668731 P2860 Q44583571 @default.
- Q73668731 P2860 Q68056139 @default.
- Q73668731 P2860 Q71039774 @default.
- Q73668731 P2860 Q72377577 @default.
- Q73668731 P2860 Q72426661 @default.
- Q73668731 P2860 Q73117412 @default.
- Q73668731 P2860 Q77530083 @default.
- Q73668731 P304 "157-161" @default.
- Q73668731 P31 Q13442814 @default.
- Q73668731 P356 "10.1023/A:1008358411251" @default.
- Q73668731 P433 "2" @default.
- Q73668731 P478 "11" @default.
- Q73668731 P577 "2000-02-01T00:00:00Z" @default.
- Q73668731 P698 "10761749" @default.
- Q73668731 P921 Q108566365 @default.
- Q73668731 P921 Q188874 @default.
- Q73668731 P921 Q238512 @default.
- Q73668731 P921 Q25493920 @default.
- Q73668731 P921 Q412197 @default.